Targeting human langerin promotes HIV-1 specific humoral immune responses
Sign Up to like & getrecommendations! Published in 2021 at "PLoS Pathogens"
DOI: 10.1371/journal.ppat.1009749
Abstract: The main avenue for the development of an HIV-1 vaccine remains the induction of protective antibodies. A rationale approach is to target antigen to specific receptors on dendritic cells (DC) via fused monoclonal antibodies (mAb).… read more here.
Keywords: specific humoral; human langerin; tfh cells; targeting human ... See more keywords